• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

AccuVein Inc.

GPOs: Novation awards new deals to AccuVein, MYCO

November 4, 2013 By Chris Walker

GPOs: Novation awards new deals to AccuVein, MYCO

Group purchasing organization Novation inked a pair of new contracts with medical device companies AccuVein and MYCO.

Filed Under: News Well Tagged With: AccuVein Inc., Group Purchasing Organizations (GPO), MYCO, Novation

Cordis CSO Rogers departs for HeartFlow | Personnel Moves

February 15, 2012 By MassDevice staff Leave a Comment

HeartFlow

Campbell Rogers is leaving his post as chief scientific officer for Johnson & Johnson’s (NYSE:JNJ) Cordis Corp. – a role created for him in July 2006 – to take the chief medical officer job at startup HeartFlow.

Filed Under: Diagnostics, News Well Tagged With: AccuVein Inc., Amedica, Amgen, Angeion Corp., AxoGen, BG Medicine Inc., BSD Medical Corp., Cordis Corp., Delcath Systems Inc., HeartFlow, Hospira Inc., Invacare, Johnson and Johnson, M*Modal, Owens and Minor, Personnel Moves, stericycle, Varian Medical Systems, Zonare Medical Systems Inc.

MassDevice Podcast: AccuVein CEO Ron Goldman

October 12, 2011 By MassDevice staff

Accuvein

Venipuncture – drawing blood or establishing an intravenous feed – is the most common invasive medical procedure. For many patients, it’s a painful exercise in frustration when clinicians struggle to find a blood vessel, sometimes requiring multiple needle sticks.

AccuVein and CEO Ron Goldman aim to change all that with the company’s AV300 vascular illumination device. The wireless, handheld module uses a pair of lasers to paint a patient’s arm with light, making otherwise invisible or hard-to-find blood vessels apparent to the naked eye.

Filed Under: Device Talks Podcasts, News Well Tagged With: AccuVein Inc., MassDevice Q&A

Medtronic lands EU approval for CoreValve | Regulatory Roundup

August 18, 2011 By MassDevice staff Leave a Comment

Medtronic

Medtronic Inc. (NYSE:MDT) won CE Mark approval in the European for its percutaneous aortic valve replacement system, CoreValve.

The device is "the only transcatheter aortic valve available in the world that can treat – without surgery – patients with larger valve openings (up to 29mm)," according to a press release.

CoreValve is the largest transcatheter valve available, but can compress into a small delivery system to be deployed in the same delivery system as smaller CoreValve sizes.

Filed Under: 510(k), Implants, News Well, Replacement Heart Valves Tagged With: AccuVein Inc., Avinger, NeuroLogica Corp., Syneron Medical Ltd., Toshiba, U-Systems, Vapotherm, Vital Images Inc., Zyga Technology Inc.

Baxter sets aside $200 million for early-stage investments | Funding/M&A Roundup

July 29, 2011 By MassDevice staff Leave a Comment

Baxter

Baxter International Inc. (NYSE: BAX) put aside $200 million in equity to invest in early-stage companies that "complement" its portfolio.

The newly established " Baxter Ventures will invest globally and focus on innovative technologies with sustainable long-term growth" under the watch of the Deerfield, Ill.-based company’s chief scientific officer Norbert Riedel, according to a press release.

Filed Under: Funding Roundup, Mergers & Acquisitions, News Well Tagged With: AccuVein Inc., Azumio, Baxter, Brooks Automation Inc., China Nuvo Solar Energy Inc., Choice Therapeutics Inc., Nexus Biosystems Inc., Phraxis Inc., Profound Medical Inc., SurgLine Inc., Venture Capital/Private Equity

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy